Cookies | Search For A Share Price | 

Uk Share Prices

Hemogenyx Pharmaceuticals Plc is a biotechnology company developing novel therapies to transform bone marrow and blood stem cell transplantation, announces the readmission of its enlarged issued share capital to the standard listing segment of the Official List and to trading on the main market for listed securities of the London Stock Exchange. The Company is the holding company for Hemogenyx LLC, a US-based biotechnology company developing therapies to transform bone marrow and blood stem cell transplantation. These therapies will replace the need for existing methods of preparation of patients for a transplantation such as chemotherapy and radiation treatments, and will address the problem of finding a matching stem cell donor and reduce the risk of blood stem cell rejection after transplantation.
Trend Direction
1 Day 1 Week 1 Month
Hemogenyx Pharmaceuticals - (HEMO) share price history
Date Open High Low Close Volume
27/06/2022 1.30 1.33 1.26 1.30 2,353,143
24/06/2022 1.30 1.35 1.27 1.30 3,951,168
23/06/2022 1.33 1.35 1.22 1.30 7,137,701
22/06/2022 1.45 1.46 1.30 1.33 4,543,105
21/06/2022 1.45 1.47 1.41 1.45 1,696,883
More Hemogenyx Pharmaceuticals History
Latest Hemogenyx Pharmaceuticals share news
More Hemogenyx Pharmaceuticals HEMO.L share news »

Top Volume Pharmaceuticals & Biotechnology Shares Price %Chng
GlaxoSmithKline 1,764.20 0.46%
Immupharma 6.17 -1.12%
Alliance Pharma 115.00 2.50%
Nuformix 0.37 0.00%
AstraZeneca 10,806.00 0.28%
Indivior 317.40 1.54%
Avacta Group 101.00 -0.79%
PureTech Health 170.60 3.02%
Synairgen 32.00 -8.57%
Scancell Holdings 13.50 -1.82%
View all sectors »
Hemogenyx Pharmaceuticals Share chat - Message board.

Data for Hemogenyx Pharmaceuticals is end of day only and updates after midnight GMT. Data is gathered from historic databases such as Quandl and other reliable sources, however errors do occur. Please use for information purposes only.
Enter share symbol
Search share prices A to Z

Sponsored Adverts